CME ACTIVITIES

 

 
Apr
7
Wed
Online Simulation Center: “Challenges in Diagnosing and Managing Migraine in the General Neurology and Primary Care Settings: Opportunities for Improved Patient Outcomes”
Apr 7 2021 @ 12:00 am – Apr 7 2022 @ 11:45 pm

Online Simulation Center: “Challenges in Diagnosing and Managing Migraine in the General Neurology and Primary Care Settings: Opportunities for Improved Patient Outcomes”

VIEW ACTIVITY

FACULTY

Dawn Buse, PhD
Clinical Professor, Department of Neurology
Albert Einstein College of Medicine
Assistant Professor, Clinical Health Psychology Doctoral Program
Ferkauf Graduate School of Psychology of Yeshiva University
Board Member at Large, American Headache Society
San Diego, CA
Uwe Reuter, MD, PhD, MBA
Professor of Neurology
Charité Universitätsmedizin Berlin
Center for Neurology, Neurosurgery, and Psychiatry
Berlin, Germany

PROGRAM OVERVIEW

This online, case-based, practice-focused activity will cover diagnosis and management strategies for headache disorders, including migraine.

TARGET AUDIENCE

This activity is intended for general neurologists and primary care providers involved in the care of patients with headache disorders, including migraine.

LEARNING OBJECTIVES

On completing the program, attendees should be able to:

  • Provide early and accurate diagnoses of headache disorders using current diagnostic criteria, best practices for differential diagnosis, and diagnostic assessment tools
  • Reduce the delay in referrals to neurologists for those patients failing to respond to standard of care therapies in the primary care setting
  • Identify patients who would benefit from acute, preventative, or both therapeutic options, and choose therapies using current evidence-based guideline recommendations
  • Apply new clinical trial data on novel agents with distinct mechanisms of action and efficacy/safety profiles for the acute and preventative treatment of migraine
  • Assess quality of life and migraine burden of individual patients to inform treatment paths that seek to improve their symptoms and achieve pain freedom

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this online activity for a maximum of 1.0 AMA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the online activity.

CNE ACCREDITATION STATEMENT

Ultimate Medical Academy/Conference Complete Management (CCM) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission of Accreditation.

NURSING CREDIT INFORMATION

Purpose: This program would be beneficial for nurses involved in the care of patients with migraine.
CNE Credits: 1.0 ANCC Contact Hour(s).

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF CONFLICTS OF INTEREST

Dawn Buse, PhD has received consulting fees from Amgen, Allergan, Biohaven, Lilly, and Teva and has received research grant support from Amgen, Allergan, the National Headache Foundation, and the US FDA.

Uwe Reuter, MD, PhD, MBA has received consulting fees from AbbVie, Allergan Eli Lilly, Novartis, Lundbeck and Teva. He serves on the Speaker Bureau for AbbVie, Allergan, Eli Lilly, Novartis, Medscape and Teva. He received non-CME/CE from Novartis. He is an Associate Editor of the Journal of Headache and Pain and Frontiers in Neurology.

CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.

CNE Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.

Staff, Planners, and Managers
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:
Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
Felecia Beachum, Program Manager for Med Learning Group, has nothing to disclose.
Marcello Morgan, MD, MPH, Medical Director for Med Learning Group, has nothing to disclose.
Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
Russie Allen, Accreditation and Outcomes Coordinator for Med Learning Group, has nothing to disclose.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and nonapproved indications.

METHOD OF PARTICIPATION

There are no fees for participating and receiving CME/CNE credit for this online activity. To receive CME/CNE credit participants must:

  1. Read the CME/CNE information and faculty disclosures.
  2. Participate in the online activity.
  3. Complete posttest and evaluation form online.

You will receive your certificate as a downloadable file.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are science-based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

AMERICANS WITH DISABILITIES ACT

Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at info@medlearninggroup.com.

For CME questions, please contact Med Learning Group at info@medlearninggroup.com.

RELEASE DATE: April 7, 2021

EXPIRATION DATE: April 7, 2022

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

Copyright © 2021 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.

VIEW ACTIVITY

 

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. These CME activities are planned and produced in accordance with the ACCME Essentials.